[Storing succinylcholine in prehospital settings following the recommendations of the French National Agency for the safety of medicines].
ACTA ACUST UNITED AC 2014;
33:395-9. [PMID:
24930762 DOI:
10.1016/j.annfar.2014.05.004]
[Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/25/2014] [Accepted: 05/14/2014] [Indexed: 10/25/2022]
Abstract
OBJECTIVE
The French National Pharmaceuticals Agency (ANSM) has recommanded in July 2012 not to break the cold chain before using succinylcholine (Celocurine®).
RESEARCH OBJECTIVE
to understand the pre-clinical evolution of the conservation modes of this curare.
RESEARCH TYPE
Descriptive study before (year 2011) and after (year 2012).
PATIENTS AND METHOD
Online survey to French Samu/Smur.
DATA COLLECTED
SMUR location, conservation method at clinical base, in the mobile unit (UMH) and at the patient. Principal decision criteria: evolution of the conservation modes before and after the recommendation (qualitatives variables compared with a Fisher test).
RESULTS
Out of 101 SAMU/SMUR, 62 answered. Conservation modes of succinylcholine vials were significantly different (P<0.001). Proper conservation was observed in 26 % of the cases before and 43 % after. Mobile units (UMH) equipped with a fridge increased from one out of two to 77 %. The lack of conservation modes passive or active on UMH went from 31 % to 3.4 % with isotherms bags with ice when a fridge was not available. The destruction of capsules at current temperature in a 24-hour period increased: 22 % before, 47 % after (P=0.04).
CONCLUSION
After recommendations from ANSM, conservation modes and destruction of succinylcholine in a prehospital environment were significantly impacted.
Collapse